Excerpts

In separate sensitivity models that combined age and GDS with one alternative geriatric instrument, depressive symptoms remained a strong and highly significant independent correlate of FACT-Cog (GDS standardized β between −0.44 and −0.57, all p < 0.001; Appendix A , Table A2 ).

Zone-specific analysis revealed highly significant differences in coverage across anatomical regions (Friedman chi2 = 450.12, p < 0.001).

This new binary variable was then subjected to an association analysis with the occurrence of a complication, and the association was highly significant ( Table 3 ; chi-squared test; p < 0.001).

The value of Bartlett’s test of sphericity was found to be highly significant (χ 2 (190) = 718.401, p < 0.001).

Bartlett’s Test of Sphericity was highly significant (χ 2 = 186, df = 15, p < 0.001), confirming that the correlation matrix differed significantly from an identity matrix and that the variables were sufficiently intercorrelated for PCA.

The risk score also showed a significant trend for in-hospital mortality in the validation cohort ( p < 0.001) ( Figure 2 B).

The results of the chi-square test indicate the existence of highly significant differences ( p < 0.001) between Kaplan–Meier curves determined for patients when stratified by tumor size.

In contrast, the FMA measurement itself showed a highly significant difference ( p < 0.001), with median values of 32.1° in the hyperdivergent group, 15.9° in the hypodivergent group, and 24.5° in the normodivergent group, which is expected given that these groups are defined by their FMA values.

A univariable extended Cox regression ( Table 2 ) demonstrated a strong and highly significant association between FRS (in percent) and graft failure (hazard ratio (HR): 1.04, 95%CI: 1.02–1.06, p < 0.001, model 1), indicating a 4% increased risk of developing graft failure over the course of 10 years, per percentage increase in the FRS.

The VIDA score showed a highly significant difference between groups, with all stable vitiligo patients classified as VIDA 0, while the active group presented with VIDA scores of +2, +3, and +4 ( p < 0.001).

Statistical analysis using the chi-square test demonstrated a highly significant association between the clinical indication and the biopsy’s effect on management ( p < 0.001).

Moreover, a negative trend was found among four groups regarding total lymphocytes, CD4 + , CD8 + and B lymphocytes ( p < 0.001, p < 0.005, p < 0.000, p < 0.044, respectively).

There was also a significant trend ( p < 0.001) for increased plaque volume with increasing number of vascular beds involved (median of 393 mm3 (IQR: 166–691 mm3) for 1 vascular bed vs. median of 657 mm3 (IQR: 339–1036 mm3) for ≥2 vascular beds ( Figure 2 ). 3.3.

Comorbidity Phenotype Trends Comorbidity phenotype trends were directionally consistent with the NE–PSY divergence: cerebrovascular and motor deficit phenotypes showed an increasing trend ( p < 0.001), neurodegenerative increased ( p = 0.001), psychiatric primary decreased ( p = 0.014), and behavioral showed no statistically significant variation ( p = 0.82) ( Figure 6 ). 3.5.2.

Birth cohort gave a highly significant contribution to this model (F = 24.16, p < 0.001), and gender and birth cohort significantly interacted (F = 2.64, p = 0.049).

Within-group analysis showed the IG achieved highly significant longitudinal improvements in pain and psychological discomfort (all p < 0.001).

There was a moderately significant positive correlation between the serum MGO levels and the TNF-α and hsCRP levels (r = 0.67 and r = 0.68, respectively, p < 0.001).

In comparison, it decreased for both high-flux HD (9.8 to 8.0%) and HDF (10.6 to 5.2%), and the difference between treatments was highly significant ( p < 0.001) [ 20 ].

In the RMS model, total RMS was not associated with BCVA (β ≈ 0.00 logMAR per μm, p = 0.997), whereas the time effect remained highly significant (β ≈ −0.97, p = 0.001).

In the CALLY analysis, the low-CALLY group had a markedly shorter median survival (20.1 months, 95% CI: 20.1–56.7) compared with the high-CALLY group (89.0 months, 95% CI: 89.0–111.3), with a highly significant difference (log-rank p < 0.001).

All preoperative-to-postoperative group differences were highly significant ( p < 0.001).

One-way ANOVA confirmed a highly significant overall difference across groups (F[3, 121] = 86.4, p < 0.001, partial η 2 = 0.68).

A second study [ 144 ] followed 20 subjects with IBDs wearing the LNG-IUS; they observed a progressive reduction in the median PBAC score over time, becoming highly significant at 12 months ( p < 0.001).

For functional disability outcomes, the 8 min protocol demonstrated a highly significant overall advantage (LME estimate: −12.84, 95% CI: −19.36 to −6.32, p < 0.001).

Generalized Estimating Equations (GEEs) confirmed a highly significant effect of time on VAS reduction ( p < 0.001).